Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PTCL) and Phase 2 atopic dermatitis trials on ...
A Frontiers editorial outlines how EEG-based biomarkers, machine learning and BCI technologies could support personalised ...
<?xml encoding="utf-8" ?> Sarepta Therapeutics SRPT reported third-quarter financial results on Thursday. The transcript from ...
A narrative review argues that age-related chronic inflammation, macrophage-driven immune signalling and blood-brain barrier ...
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations ...
When the mid-IR laser is tuned to a wavelength that excites molecular vibrations in the sample, absorption of IR energy ...
Ladies and gentlemen, thank you for standing by. Welcome to Arcutis Biotherapeutics Third Quarter 2026 Earnings Conference ...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies for autoimmune diseases, hematologic ...
Sarepta’s Q3 2026 earnings call covered $324 million in product revenue, higher 2026 guidance, Elevidys stabilization and ...
King Fahd University of Petroleum and Minerals (KFUPM) is inviting prospective researchers to explore fully funded PhD and ...
Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results